Methods of preventing bacterial sepsis and wound complications for liver transplantation

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Gurusamy, Kurinchi Selvan ^a   Kumar, Y ^b   Davidson, B R ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LACTIC ACID; PREBIOTIC AGENT; PROBIOTIC AGENT;

ABDOMINAL SURGERY; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; DIETARY FIBER; ENTERIC FEEDING; GASTROINTESTINAL INFECTION; GRAFT DYSFUNCTION; GRAM NEGATIVE BACTERIUM; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCISIONAL HERNIA; INTENSIVE CARE; LENGTH OF STAY; LIVER TRANSPLANTATION; METHODOLOGY; MORBIDITY; MORTALITY; REOPERATION; RETRANSPLANTATION; REVIEW; RISK FACTOR; SEPSIS; WOUND COMPLICATION;

EID: 44949120792     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006660     Document Type: Review

References (38)

1. Blair 2005 Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation - part I. Liver Transplantation 2005;11(12):1452-9.
2. Bombuy 2004 Bombuy E, Fondevila C, Rodriguez-Laiz G, Ferrer J, Amador A, Valentini M, et al.Ischemic preconditioning in adult living donor liver transplantation, a pilot study [EASL abstract]. Journal of Hepatology 2004;40(Suppl 1):39.
3. Cescon 2006 Cescon M, Grazi GL, Grassi A, Ravaioli M, Vetrone G, Ercolani G, et al.Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transplantation 2006;12(4):628-35.
4. Corno 2006 Corno V, Colledan M, Dezza MC, Guizzetti M, Lucianetti A, Maldini G, et al.Extended right split liver graft for primary transplantation in children and adults. Transplantation International 2006;19(6):492-9.
5. DeMets 1987 DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
6. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
7. Egger 1997 Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
8. Garbino 2005 Garbino J, Romand JA, Pittet D, Giostra E, Mentha G, Suter P. Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience. Swiss Medical Weekly 2005;135(39-40): 587-93.
9. Gluud 2007 Gluud C, Nikolova D, Klingenberg SL, Als-Nielsen B, D'Amico G, Davidson B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2007, Issue 2. Art. No.: LIVER.
10. Haddad 2006 Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD005161. DOI: 10.1002/14651858.CD005161.pub2.
11. Hellinger 2002 Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, et al.A randomized, prospective, double-blinded evaluation of selective bowel decontamination in. Transplantation 2002;73(12): 1904-9.
12. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
13. Higgins 2006 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Intervention 4.2.6 [updated September 2006]. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd.
14. Hodson 2005 Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GFM, et al.Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003774. DOI:10.1002/14651858.CD003774.pub2.
15. Kamath 2001 Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al.A model to predict survival in patients with endstage liver disease. Hepatology 2001;33(2):464-70.
16. Kato 2005 Kato T, Yoshida H, Sadfar K, Martinez E, Nishida S, Moon J, et al.Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study. Transplant Proceedings 2005;37(2):1217-9.
17. Kjaergard 2001 Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
18. Koneru 2005 Koneru B, Fisher A, He Y, Klein KM, Skurnick J, Wilson DJ, et al.Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transplantation 2005;11(2):196-202.
19. Lim 2006 Lim SG, Wai CT, Da Costa M, Sutedja DS, Lee YM, Lee KH, et al.Referral patterns and waiting times for liver transplantation in Singapore. Singapore Medical Journal 2006;47(7):599-603.
20. Macaskill 2001 Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4):641-54.
21. Mehrabi 2006 Mehrabi A, Fonouni H, Wente M, Sadeghi M, Eisenbach C, Encke J, et al.Wound complications following kidney and liver transplantation. Clinical Transplantation 2006;20(Suppl 17):97-110.
22. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
23. Newell 1992 Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837-41.
24. NHS UK transplant NHS UK Transplant - Annual Report 2003-2004. http://www.uktransplant.org.uk/ukt/about_us/annual_report/ archive_annual_reports/ann_report_2003_2004.pdf (accessed 22 May 2007).
25. OPTN/SRTR 2005 The Organ Procurement and Transplant Network/ Scientific Registry of Transplant Recipients 2005 Annual Report. http://www.ustransplant.org/annual_reports/current/905_li.pdf (accessed 22 May 2007).
26. Piazzese 2004 Piazzese E, Montalti R, Beltempo P, Bertelli R, Puviani L, Pacile V, et al.Incidence, predisposing factors, and results of surgical treatment of incisional hernia after orthotopic liver transplantation. Transplantation Proceedings 2004;36(10):3097-8.
27. Playford 2004 Playford EG, Webster AC, Sorell TC, Craig JC. Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004291. DOI: 10.1002/14651858.CD004291.pub2.
28. Rayes 2002 Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al.Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002;74(1):123-7.
29. Rayes 2005 Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al.Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. American Journal of Transplantation 2005;5(1):125-30.
30. RevMan 2003 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
31. Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
32. Safdar 2004 Safdar N, Said A, Lucey MR. The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis. Liver Transplantation 2004;10(7):817-27.
33. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
34. Schwartz 1997 Schwartz SI. Hepatic resection. Maingot's Abdominal Operations. 10. Vol. I, USA: Appleton and Lange, 1997.
35. Shiffman 2006 Shiffman ML, Saab S, Feng S, Abecassis MI, Tzakis AG, Goodrich NP, et al.Liver and intestine transplantation in the United States, 1995-2004. American Journal of Transplantation 2006;6(5 Pt 2):1170-87.
36. Strippoli 2006 Strippoli GF, Hodson EM, Jones CJ, Craig JC. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005133. DOI:10.1002/14651858.CD005133.pub2.
37. Sweeting 2004 Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine 2004;23(9):1351-75.
38. van 't Riet 2002 van 't Riet M, Steyerberg EW, Nellensteyn J, Bonjer HJ, Jeekel J. Meta-analysis of techniques for closure of midline abdominal incisions. British Journal Surgery 2002;89(11):1350-6.